These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 18477644)

  • 1. Advances in tumour immunotherapy.
    King J; Waxman J; Stauss H
    QJM; 2008 Sep; 101(9):675-83. PubMed ID: 18477644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer immunotherapy.
    Baxevanis CN; Perez SA; Papamichail M
    Crit Rev Clin Lab Sci; 2009; 46(4):167-89. PubMed ID: 19650714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.
    Khalil DN; Smith EL; Brentjens RJ; Wolchok JD
    Nat Rev Clin Oncol; 2016 May; 13(5):273-90. PubMed ID: 26977780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunomodulation in the treatment of haematological malignancies.
    Cesco-Gaspere M; Morris E; Stauss HJ
    Clin Exp Med; 2009 Jun; 9(2):81-92. PubMed ID: 19238515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer immunotherapy, particularly in combination with androgen deprivation or radiation treatment. Customized pharmacogenomic approaches to overcome immunotherapy cancer resistance.
    Alberti C
    G Chir; 2017; 37(5):225-235. PubMed ID: 28098061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy II: Antigens, receptors and costimulation.
    Searle PF; Young LS
    Cancer Metastasis Rev; 1996 Sep; 15(3):329-49. PubMed ID: 9034595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of cancer immunotherapeutic strategies.
    Wahid B; Ali A; Rafique S; Waqar M; Wasim M; Wahid K; Idrees M
    Immunotherapy; 2018 Aug; 10(11):999-1010. PubMed ID: 30149763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Immunotherapy for cancer--modern immunologic strategies in oncology].
    Halama N; Zoernig I; Jäger D
    Dtsch Med Wochenschr; 2008 Oct; 133(41):2105-8. PubMed ID: 18985564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAR T-cell Therapy: A New Era in Cancer Immunotherapy.
    Miliotou AN; Papadopoulou LC
    Curr Pharm Biotechnol; 2018; 19(1):5-18. PubMed ID: 29667553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adoptive transfer of murine T cells expressing a chimeric-PD1-Dap10 receptor as an immunotherapy for lymphoma.
    Lynch A; Hawk W; Nylen E; Ober S; Autin P; Barber A
    Immunology; 2017 Nov; 152(3):472-483. PubMed ID: 28670716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunotherapeutic approaches for cancer therapy: An updated review.
    Kazemi T; Younesi V; Jadidi-Niaragh F; Yousefi M
    Artif Cells Nanomed Biotechnol; 2016 May; 44(3):769-79. PubMed ID: 25801036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploiting T cell receptor genes for cancer immunotherapy.
    Xue S; Gillmore R; Downs A; Tsallios A; Holler A; Gao L; Wong V; Morris E; Stauss HJ
    Clin Exp Immunol; 2005 Feb; 139(2):167-72. PubMed ID: 15654813
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunotherapy for colorectal cancer].
    Tougeron D; Fauquembergue É; Latouche JB
    Bull Cancer; 2013 Sep; 100(9):871-85. PubMed ID: 23917703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broadly expressed tumour-associated proteins as targets for cytotoxic T lymphocyte-based cancer immunotherapy.
    Bendle GM; Holler A; Downs AM; Xue SA; Stauss HJ
    Expert Opin Biol Ther; 2005 Sep; 5(9):1183-92. PubMed ID: 16120049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chimeric T-cell receptors for the targeting of cancer cells.
    Rössig C; Brenner MK
    Acta Haematol; 2003; 110(2-3):154-9. PubMed ID: 14583676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive cell therapy: Honing that killer instinct.
    Humphries C
    Nature; 2013 Dec; 504(7480):S13-5. PubMed ID: 24352359
    [No Abstract]   [Full Text] [Related]  

  • 17. [Era of cancer immunotherapy has come].
    Nakatsura T
    Nihon Rinsho Meneki Gakkai Kaishi; 2016; 39(3):164-71. PubMed ID: 27320931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific immunotherapy of cancer in elderly patients.
    Matzku S; Zöller M
    Drugs Aging; 2001; 18(9):639-64. PubMed ID: 11599633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New clinical advances in immunotherapy for the treatment of solid tumours.
    Zavala VA; Kalergis AM
    Immunology; 2015 Jun; 145(2):182-201. PubMed ID: 25826229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Designer T-cells and T-cell receptors for customized cancer immunotherapies.
    Legut M; Sewell AK
    Curr Opin Pharmacol; 2018 Aug; 41():96-103. PubMed ID: 29852403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.